(4):608.
[5]null?2?.
"50tí
[M].?2?.?:|
? +D?
,
2001:471.
[6]null
WU. g??0- 5o[J].?S0D?,1998,23(4):
246.
[7]null??,§ ?±,?EC.O?
í?4?￥ù?D 7?[J].0
DéZ,2001,75(2):81.
[8]null ù￡,?yZ,u?
. g?O?
í?4￥ù?éZ[J].3
b +0DD,2001,17(3):154.
[9]null?null
1.Uh￥0tí
[J].?êD0,1997,37(12):37.
[10]nullH? I,\ ),|?V.Uh￥?
J
E[J].
H?S0ù
?,1997,8(6):553.
[11]null?
ü?,R×ó,}`.?D2?í
Uh￥
"5ù?
[J].?SD <,2001,36(3):49.
[12]null{á?,
ìI
.hUh￥?
E[J].??D0ù?,2001,
11(2):128.
[13]nullfIo,???,
S
±?.O?í
Uh312 è
"543
[J].???D,2000,17(2):4.
[14]nullf
~
,
+nullé,f? ?,?.?h??e$?NODl
?ó
T¨￥0rDù?[J].?S?D2?á??,1997,5(2):
95.
[15]null?AW.h W?áy
ù1 è?[J]. 2?D?,1994,15
(5):29.
là°ù:2001-12-02
?? ?x?4￥
"5?¨o
战克勤1,夏海武2(1nulloX
g|
?Dy,oXnull261041;2nulloXDy,oXnull261043)
K1null"￥:介绍双黄连粉针剂的临床新用途bZE:通过查阅文献,综合报道该药在临床上的新用途b2
T:双黄连粉针剂可用于病毒性心肌炎a小儿疱疹性咽峡炎a小儿喘息急性发作a小儿腹泻a眼科病a手足口
病a气道痰阻证a口腔溃疡a生殖器疱疹a褥疮等疾病b2
?:双黄连粉针剂具有广谱抗菌a抗病毒和免疫调节
等作用b
1oMnull双黄连粉针剂;新用途;广谱抗菌
?ms ?|:R972nullnullnullóDS
M
?:BnullnullnullnullócI|:1006-0111(2002)03-0140-03
nullnull
?? ?x?41B?0?4,??ùaá?a
?Iü4|ú?7?, μb￡3yab??￡￥?
rb?1¨?hya% )??￥
????ak
aK%8aó?,íM ?
"5￥?¨? ??
<W,Cà
??/b
1nullí
hy??
?[1],¨
?? ?x?4í
l8hy??
32 è,è?F30 è,è?F¨?
?F20~
40mgnulld-1,￡
?A100~200Unulld-1,?
3
íC2~3gnull
d-1,1,6-=
?T5gnulld-1,iv, ?¨3wk,
?? ?F
"
?è?í
?,]
HF
?? ?x?4
?°60mg
nullkg-1,iv, ?¨2wk,2Tü (í??
?:
?? ?F
12null0null6null2d,è?F16null0null8null5d,
FμA÷?μs
(P<0null05)bO
?? ?F?????8T
%?
%??sè#
?f????￥sè,VC CD4
+
/?,CD8+
6,CD4+nullCD8+/?b
2nullí
l8k??ó,[2]
l8k??ó,??132 è,í
F87 è,
vF45 è,í
F¨
?? ?x?4
?°60mgnull
kg-1,·?5%?$100~250ml,iv,qd,3dB
?b
vF¨hy:
?Q5mgnullkg-1,F?5%?$100
~250ml,iv,bid,3dB
?,2Tí
Fí?63 è,
z21 è,9μr
q96null5%bvFí?9 è,z
20 è,9μr
q64null6%b
Fí?
q μA÷μ
sbí
F|￡ü (2d,k?h|ü (3null5d,v
F|￡ü (3null5d,k?h|ü (5null5db
3null?
2ü??í
l80$??T[3]
l8|5e0a0?|5￥0X$?
?T
^8 Sèn$?bí
F¨
?? ?x?4
300mgF
3 ?÷
￡10ml,?
<
￡10ml,
da?
2ü
??,
?Q10~15min,^??
?l
H1Q,×??
?l
H2~3QbvF¨iv
?
í40000UF
3
?÷
￡10ml,?
<
￡10ml,
da?
2ü??,
?]í
Fb2Tí
F80 è,Ar56 è,μr24
èb9μr
q100%bvF80 è,Ar22 è,μ
r32 è,9μr
q67null5%(P<0null05)b
4nullí
l8l1′?
?[4],|
?? ?x?4
?°60mgnullkg-1F
250ml
3 ?÷
￡5%?$÷
￡,iv,qd,í
l8
l1′?,2T31 è?8??í?,ü (???
?
2null23d,18 è?￡??2d=|￡,′e?
"5?h
>b
6 ?[5],|l1′??8226 è
?s13
140TheJournalofPharmaceuticalPracticeVol.202002No.3
F,iüvL
}hy Fe_?1 ??128 è(
?
q56null64%)b?1F1
?? ?
=9?F(í
F)78 è;?2F1
?? ?á?73 è;?3F1hy
:á?75 èb?1F¨
?? ?60mgnullkg-1·?36null
3 ?÷
￡5ml?9?,?9?a?, ?91Q,
?2F¨]4
?? ?·?5%?$250ml,iv,
qd,?3Fhy:10~15mgnullkg-1·?5%?$
250ml,iv,qd,μ?
￡?óí??è3é?
y,?
1998M?S′??p??S,2T72ha3FA
rsY163 è,37 è,9μr
qsY197null44%,
75null34%,46null67%b3FμA÷?μs(P<0null01)b
}hy Fe ??8í
72haˉ°vL
}h
y Fe,|
q3FsY186null96%,61null54%,
32null56%,
?? ?9?F
üAa?vF,O
?? ?
9?í
l1′?, V
PvL?
?fo?a(SigA)
c
üA9F,μr F
}hy??,F y??
?ˉb
5nullí
Sh
5null1null治疗复视[6]
1 èˉ
j??,;?S 1??í?,1moa?
ˉ?,O
????,¨
?? ?x?43|·?
5%?$250ml,iv,qd,?2Qa,??
???,
7
j $X?è, ???ˉ6Q? Cˉ
jb
5null2null治疗急性结膜炎[6]
$?.??2??¨
?? ?x?46|,
3 ?÷
￡500ml,iv,qd,2Tí
25 è,1~3d?
h^,3~6d??b
5null3null治疗单疱病毒性角膜炎
?[7],¨
3 ?÷
￡500mlF
?? ?x?4
3null6g,iv,qd,14d11
?,]
H¨hy:#v?ì
?
￡ˉ,2T
?????í?,ü (16dí
?;
Lé??í?5,z2,ü (27dí?;?
?
í??í?4,z1,ü (35dí?b
6nullí
m@ gh[8]
m@ gh??488 è,¨
?? ??
A1mlnull
kg-1F?250ml
3 ?÷
￡,iv,qd,2T2dí?48
è,3dí?106 è,4dí?160 è,5dí?74 è,ü
(3null67dí?,vF(]
?
íahy:)ü (5null58d
í?b
7nullí
?E￡[9]
¨
?? ?x?4300mg,
??a25mg,7e í
15mlF
3 ?÷
￡5ml?ó (?
?? ?ü?4b
vF¨iv
?
í40000U,null-
??a
?50mg,?ˉa
0null125g,F
3 ?÷
￡20mlF?0ü?4b
P¨?
2ü?(üˉ0null9~1null5nullm),bid,
?Q15~20min,
7dB
?,431~2
?,2Tí
F106 è,
"5
e?20 è,Ar39 è,μr38 è,9μr
q
91null5%,vF100 è,
"5 e?18 è,Ar28 è,
μr35 è,9μr
q81%,
FμA÷μs(P<
0null05)b
8null¨? g8 ?
μ|?[10],?¨
?? ?x?4??í
g8
?38 è,?Qˉ? g8 ?7 è,×? g8 ?4
èb|
?? ?x?41g,¨2% ? 5y?
A
a
??′,¨
??[
?0′??),?10
~30min,tid,¨02~4db2Tí?29 è,μr8
è,9μr
q97null4%b
9nullí
32k?[11]
32k?"-
í+r
E,|
?? ?x?
4¨
3 ?÷
￡?
¨
￡￥?10%￥·A,|4~5
ahyí?¨0A?
A???)??
A?,
??à
A?2~4h,í
A?Hq?
???20A8~10
Q,7dB
?,
?
?43
r,
?]h|a,?
?
??20A3~4Q, ??7~10d,2Tí
32
k?100 è,392 è,o8 è,??
qr89%,9
μr
q100%b
10nullí
?2[12]
?2??30 è,óí ???b2hya,?
¨
?? ?x?40null6g, (p???2 ?
?,?
a?[í )í?,??%?,qd,10~14d1B
?,
2T??
q196null7%,9μr
q1100%b
? IóD:
[1]null
S?,
>?
?,?null
!,?null?
¨
?? ?í
l8hy?
?
r43[J]null?S?D2??,1998,18(10):601.
[2]nullú?vnull
?? ?x?í
l8k??ó,87 è[J]null?S
?D2??,2000,20(1):830.
[3]null ùD
2, ùò?null
?? ?x??
2ü??í
l80$
??T80 è
"543[J]null??D,1997,29(3):19.
[4]null
?? +,
￥Dnull
?? ?á
?ˉ?í
l8l1′?31 è
[J]null??D,1997,29(11):45.
[5]null?r
~,
?￡í,??ónull
?? ?
=9?í
??8l1′
?￥
r43[J]null?S?D2??,2000,20(3):217.
[6]null1
ol,?á?null
?? ?x?í
Sh[J]null??0,1997,
19(4):50.
[7]null???null
?? ?áˉí
?khy??25 è[J]null??
D,2001,33(6):60.
[8]nullfD
null
?? ??
Aí
m@ gh488 è[J]null?D?,
2000,41(1):55.
[9]null
>?
3,
?<÷,=null?null
?? ?ü?4í
?E￡106
è
"543á[J]null<ü?DDyD,1994,11(2):61.
[10]nullBID,
g;?? ?x?4??í
g8 ?[J]null?ê
1410D
Ll?2002M?20 ?3ù
?D?,1999,18(1):40.
[11]null
.￡null?0
?? ?x?A?¨í
32k?100 è[J],
?S???hD?,1994,8(4):234.
[12]null
?nullónull
?? ?x?4í
?230 è43[J]null?D2?
?,1993,13(12):696.
là°ù:2001-12-17
-
FE1
"5?¨C
田null健(3b +538Dy,q?null723102)
K1null"￥:本文总结前列腺素E1(PGE1)在内科临床应用现状bZE:通过查阅临床资料进行回顾性结果
分析b2T:PGE1通过抑制血小板聚集a免疫复合物及血栓素A2生成;并可稳定细胞膜的作用b防止血管
痉挛和血栓形成,改善微循环等生理活性b2
?:在内科系统应用中,发挥其显著的作用b
1oM:前列腺素E1;血栓素A2;细胞膜
?ms ?|:R983nullnullnullnullóDS
M
?:BnullnullnullnullócI|:1006-0111(2002)03-0142-02
nullnull-
F
í
^BFμ ?
3t?￥té, ó
5=?%?YVì ?T¨,a?
3
1
?á
3b
? 2?]μAaBaCaDaEaFaGaI??,?
-
F
íE1?óle￥F
?ì?
?,
Pó
le=￥ì
?Fc
6ú,V7]?ó
?
íA2
￥
db,]?óleT?
q, ?fó5bi V4úó
5=?%=ì
?F
￡ü,]??
??"??
ê v??b
1null
"5?¨
1null1null治疗糖尿病足部病变
Uh@?hM(??Uh@)
^UhKè
n￥i??-Bb?1VC1@? ?,??ê
,
?Mv?μ1%￥Uh??yN731?ab
"-a1±?ì??sèal?
????ó
?
^
Uh@￥?h?bQnull?Uh??óA)?
ú`
?,óle
"
üA9ú^??ó
?bPGE1
^ μ<W
3 ??￥té,
? V[]??
???
#ê v??,]?óle
"#ó
??A2(TXA2)￥
??, ?fó5μr1??
?ìbf?ú[1]?
?¨PGE1í
null?Uh@??42 è,| b′
ó e? 4null4~6null7mmolnullL-1,?a2hó<
8null3mmolnullL-1S?=b?¨PGE11200nullg+
3 ?÷
￡
500ml,á
??ˉ,
??1Q,4wk11
?b?í
-a???_°
?/a@ ?
?5?,ó
@
#ó
@?
H
?,2Tí
-Dí
a1?μdèA
÷μs(P<0null01)b
1null2null治疗肺心病
k?
?úa
^?k?h￥5 %Hqb
?:B? aú
?ó?#??
??y,YV
ü8A??kó5
l
êa?
uak?ìE ?9
Fb=
¤?? ????￡%9 ,óAT
9FbPGE1 VYV??PGI2nullTXA2￥1′,]
?ó5?
u?ó
???b?μr1 ?fkó5?
?kó5E ??k?
?a,V7??k?
?úab
R?é[2]??¨?
@
?PGE1 ó??
@
12 èk?h??óA? ?DaóaF?
(DO2)?F? h{(VO2)￥T¨é?ù?b2
T:?Bóí?
@
,k?
?a(mPAP)^
??,?óA? ?D?
?
àμA÷M?;?
?ó
sa(PaO2)a?
?ó ?(SaO2)??á
?ó
?(SvO2)sY9F13null2%a13null6%?10null9%b
DO2aVO2sY9F13null2%a23null6%bPGE1 ó?
(FIO2127%)a,mPAPak?ìE ?sY??25%
?41null9%b??ó·
?9F12null9%,PaO2aSaO2a
SvO2aDO2?VO2sY9F
32null2%a11null1%a
25null6%a31null7%?19null1%b
1null3null对心肌缺血null再灌注损伤的保护作用
?V???PGE1 μ ?fó59F§￥?
ì9F?
{
￥T¨bPGE1?? VYV9F?
ó[1?ó?;? VYV]?a%?
h
1?￥á
3V7h^ 9?
?
[3]b|z
ù[4]??¨?t
L43PGE1?ónull 9??
￥?Y,2TV
üPGE1?μK1]??ó?
ù??èmST
úú,h
?ónull 9??
￥z??ó?,
êlü
μ
?b
1null4null治疗心绞痛
μ?·,PGI2nullTXA2￥
>?
^?á?×??
142TheJournalofPharmaceuticalPracticeVol.202002No.3
|
|
